Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Infinium PharmachemNSE:INFINIUM +0.57%87 PEG Ratio is 0.94 as of Jul. 21, 2026, which is 6% above its 10-year median of 0.89. GuruFocus rates NSE:INFINIUM with a GF Score™ of 87/100 and a GF Value™ of ₹305.70 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 613 Chemicals companies, Infinium Pharmachem ranks better than 76.67% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Infinium Pharmachem's PEG Ratio or its related term are showing as below:
NSE:INFINIUM'
s PEG Ratio Range Over the Past 10 Years
Min: 0.69 Med: 0.89 Max: 1.13
Current: 0.94
During the past 7 years, Infinium Pharmachem's highest PEG Ratio was 1.13. The lowest was 0.69. And the median was 0.89.
NSE:INFINIUM's PEG Ratio is ranked better than 76.67% of 613
companies
in the Chemicals industry
Industry Median: 2.04
vs NSE:INFINIUM: 0.94
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Infinium Pharmachem (NSE:INFINIUM) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Infinium Pharmachem PEG Ratio Related Terms
Infinium Pharmachem PEG Ratio Historical Data
* Premium members only.
The historical data trend for Infinium Pharmachem's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Infinium Pharmachem's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Infinium Pharmachem PEG Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Infinium Pharmachem's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Infinium Pharmachem's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Infinium Pharmachem (NSE:INFINIUM) has a PEG Ratio of 0.94 as of Jul. 21, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Infinium Pharmachem and its competitors. This is near median its historical median of 0.89. Over the past decade, Infinium Pharmachem's PEG Ratio has ranged from 0.69 to 1.13. According to the industry distribution chart, Infinium Pharmachem ranks #143 out of 613 companies in the Chemicals industry, placing it in the top 23.3%.
Is Infinium Pharmachem's PEG Ratio too high?
Infinium Pharmachem's current PEG Ratio of 0.94 is near median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 1.13. The Chemicals industry median PEG Ratio is 2.04. Infinium Pharmachem's value of 0.94 is 53.9% below this industry median. Based on the distribution chart, Infinium Pharmachem ranks #143 out of 613 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Infinium Pharmachem has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Infinium Pharmachem's PEG Ratio compare to DOW?
According to the Chemicals industry distribution chart, Infinium Pharmachem ranks #143 out of 613 companies for PEG Ratio. This places Infinium Pharmachem in the top 23% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 2.04. Infinium Pharmachem's value of 0.94 is 53.9% below this benchmark. Historically, Infinium Pharmachem's own PEG Ratio has ranged from 0.69 to 1.13 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 2.04, Infinium Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Chemicals company?
The median PEG Ratio among Chemicals companies is 2.04, based on 613 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Infinium Pharmachem's current PEG Ratio of 0.94 is 53.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Infinium Pharmachem and its competitors. For the Chemicals industry, the median PEG Ratio is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Infinium Pharmachem's current PEG Ratio is 0.94, which is near median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Infinium Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Infinium Pharmachem (NSE:INFINIUM) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹305.70, compared to a current price of ₹210.70 — trading 31.1% below its estimated fair value. The current PEG Ratio is 0.94, which is near median its 10-year median of 0.89 and 53.9% below the Chemicals industry median of 2.04. Infinium Pharmachem's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Infinium Pharmachem (NSE:INFINIUM), the current PEG Ratio is 0.94 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Infinium Pharmachem (NSE:INFINIUM) Overvalued in 2026?
Based on GuruFocus' analysis, Infinium Pharmachem stock appears to be undervalued.
The current stock price of ₹210.70 is trading 31.1% below its estimated GF Value™ of ₹305.70.
GuruFocus considers Infinium Pharmachem to be Significantly Undervalued.
Key valuation signals for NSE:INFINIUM:
PEG Ratio: 0.94 (near median its 10-year median of 0.89)
GF Value™: ₹305.70 vs. price of ₹210.70 (31.1% below fair value)
Industry Position: 53.9% below the Chemicals median (#143 of 613)
No single metric tells the full story. See the NSE:INFINIUM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Infinium Pharmachem Ltd is engaged in the business of manufacturing and supplying Iodine, Iodine Derivatives and Active Pharmaceutical Ingredients (APIs). It provides fully integrated customized services from R & D to Commercial scale manufacturing and packaging for its products to the Pharmaceutical, Agrochemical, Nutraceutical, Speciality Chemicals and various other chemicals Industries.
87GF Score
Get the complete analysis for NSE:INFINIUM
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INFINIUM has been successfully added to your 
